by Van Andel Research Institute Graphical abstract. Credit: Cell Metabolism (2023). DOI: 10.1016/j.cmet.2023.03.008 A team led by Van Andel Institute and Max Planck Institute of Immunobiology and Epigenetics scientists has identified two distinct subtypes of insulin-producing beta cells, or ß cells, each with crucial characteristics that may be leveraged to better understand and treat type 1 and type...
By Michael Irving June 13, 2022 Researchers in Sweden have uncovered how a molecule could help regenerate insulin-producing cells in the body as a new potential diabetes treatment Depositphotos An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have now identified a...
UNIVERSITY OF WISCONSIN-MADISON MADISON, Wis. — Researchers have discovered a previously unknown way that pancreatic cells decide how much insulin to secrete. It could provide a promising new target to develop drugs for boosting insulin production in people with Type 2 diabetes. In a pair of papers recently published in Cell Metabolism, scientists from the University of Wisconsin-Madison...
by Chris Barncard, University of Wisconsin-Madison Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows. The cellular sleight-of-hand may suggest ways to prevent Type 1 diabetes in high-risk individuals, as well as...
